Physician

Beth K Bruening, M.D.

According to 2025 Medicare claims, Beth Bruening, M.D. (NPI: 1467423517) practices ophthalmology in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is BETH BRUENING PC (NPI: 1053446443; TIN: 421439968) and primary practice location at 51106-4712.

Bruening's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,245 traditional Medicare patients, billed 6,155 HCPCS/CPT codes, and received $776,187 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,250 prescription claims across 535 beneficiaries totaling $123,074 in drug costs, led by Lumigan (Bimatoprost). 2020 DME data shows 30 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $231,066 and ending at $123,074. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,010	8,446	$806,170
2016	1,984	8,390	$818,077
2017	2,008	10,096	$1,041,421
2018	1,938	10,087	$1,174,506
2019	1,833	9,579	$1,161,769
2020	1,598	8,222	$1,027,141
2021	1,543	7,658	$924,841
2022	1,316	7,131	$821,996
2023	1,212	5,939	$734,897
2024	1,245	6,155	$776,187

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	495	2,963	$231,066
2016	623	3,615	$318,186
2017	725	3,669	$350,134
2018	740	3,971	$342,721
2019	784	3,409	$355,912
2020	785	3,596	$304,651
2021	746	3,045	$267,284
2022	650	2,454	$197,913
2023	545	2,170	$279,191
2024	535	2,250	$123,074

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	121	121	$7,723
2016	162	163	$10,107
2017	106	106	$6,161
2018	214	214	$13,451
2019	217	220	$12,717
2020	30	30	$1,697
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	391	615	$82
92014	Established patient complete exam of visual system	736	743	$80
92083	Exam of visual field with extended testing	231	265	$42
92134	Imaging of retina	517	849	$27
92133	Imaging of optic nerve	435	460	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	77	4,177	$35,523
Restasis	Cyclosporine	18	1,080	$21,992
Brimonidine Tartrate	Brimonidine Tartrate	242	13,710	$9,415
Prednisolone Acetate	Prednisolone Acetate	205	6,997	$8,629
Latanoprost	Latanoprost	643	41,818	$8,299

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Beth K. Bruening, M.D.?

Tedicare shows public-source Medicare data for Beth K. Bruening, M.D. (NPI 1467423517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Beth K. Bruening, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Beth K. Bruening, M.D.?

Beth K. Bruening, M.D. is linked to BETH BRUENING PC (billing NPI 1053446443) in the available physician profile data.

Does Beth K. Bruening, M.D. have Open Payments data?

Beth K. Bruening, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.